Average Insider

Where insiders trade, we follow

Denali Therapeutics Inc. ($DNLI)
Accession: 0001193125-26-259680
Jun 5, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$12.58
Current$24.4080.3% above low, 19.7% below high
52W High$27.30

Filing Information

Accession Number0001193125-26-259680
Form Type4
Filing DateJun 5, 2026
DocumentView SEC Filing
Transactions
4
Total Shares
51,268
Total Value
$0.00
P&L
+inf% (+$1,250,939.20)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
BAKER BROS. ADVISORS LP
Director
Common Stock
โ€”Jun 3, 2026Grant/Award6,408$0.00$0.00343,275IndirectSee FootnotesView Details
BAKER BROS. ADVISORS LP
Director
Common Stock
โ€”Jun 3, 2026Grant/Award6,408$0.00$0.003,422,366IndirectSee FootnotesView Details
BAKER BROS. ADVISORS LP
Director
Non-Qualified Stock Option (right to buy)
(Common Stock)
DerivativeJun 3, 2026Grant/Award19,226$0.00$0.0019,226IndirectSee FootnotesView Details
BAKER BROS. ADVISORS LP
Director
Non- Qualified Stock Option (right to buy)
(Common Stock)
DerivativeJun 3, 2026Grant/Award19,226$0.00$0.0019,226IndirectSee FootnotesView Details
Version: v26.7.3